Adage Capital Partners’s Xenon Pharmaceuticals XENE Stock Holding History

Adage Capital Partners’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$40.4M	Sell	1,290,100 -624,649	-33%	-$19.6M	0.07%	284
2025 Q1	$64.2M	Buy	1,914,749 +51,276	+3%	+$1.72M	0.12%	171
2024 Q4	$73M	Sell	1,863,473 -220,499	-11%	-$8.64M	0.13%	156
2024 Q3	$82M	Buy	2,083,972 +244,417	+13%	+$9.62M	0.14%	142
2024 Q2	$71.7M	Buy	1,839,555 +167,638	+10%	+$6.54M	0.13%	160
2024 Q1	$72M	Buy	1,671,917 +623,192	+59%	+$26.8M	0.14%	158
2023 Q4	$48.3M	Buy	1,048,725 +498,725	+91%	+$23M	0.1%	217
2023 Q3	$18.8M	Sell	550,000 -120,000	-18%	-$4.1M	0.04%	409
2023 Q2	$25.8M	Sell	670,000 -80,000	-11%	-$3.08M	0.06%	342
2023 Q1	$26.8M	Buy	750,000 +25,000	+3%	+$895K	0.06%	344
2022 Q4	$28.6M	Buy	725,000 +50,000	+7%	+$1.97M	0.07%	329
2022 Q3	$24.4M	Buy	675,000 +45,000	+7%	+$1.62M	0.06%	353
2022 Q2	$19.2M	Sell	630,000 -20,000	-3%	-$608K	0.04%	443
2022 Q1	$19.9M	Sell	650,000 -15,000	-2%	-$459K	0.04%	453
2021 Q4	$20.8M	Sell	665,000 -510,000	-43%	-$15.9M	0.04%	449
2021 Q3	$18M	Sell	1,175,000 -350,000	-23%	-$5.35M	0.04%	498
2021 Q2	$28.4M	Sell	1,525,000 -1,025,000	-40%	-$19.1M	0.06%	350
2021 Q1	$45.6M	Buy	2,550,000 +100,000	+4%	+$1.79M	0.09%	224
2020 Q4	$37.7M	Hold	2,450,000	–	–	0.08%	270
2020 Q3	$27.1M	Buy	2,450,000 +425,000	+21%	+$4.7M	0.07%	299
2020 Q2	$25.4M	Hold	2,025,000	–	–	0.07%	326
2020 Q1	$23M	Buy	2,025,000 +100,000	+5%	+$1.13M	0.07%	296
2019 Q4	$25.2M	Buy	1,925,000 +625,000	+48%	+$8.19M	0.06%	337
2019 Q3	$11.7M	Hold	1,300,000	–	–	0.03%	491
2019 Q2	$12.8M	Hold	1,300,000	–	–	0.03%	478
2019 Q1	$13.2M	Hold	1,300,000	–	–	0.03%	474
2018 Q4	$8.2M	Buy	1,300,000 +100,000	+8%	+$631K	0.02%	542
2018 Q3	$15.8M	Buy	1,200,000 +400,000	+50%	+$5.28M	0.04%	460
2018 Q2	$7.36M	Buy	+800,000	New	+$7.36M	0.02%	609